Dopamine transporter immunoreactivity in peripheral blood mononuclear cells in amyotrophic lateral sclerosis
- 21 April 2006
- journal article
- Published by Wiley in European Journal of Neurology
- Vol. 13 (4) , 416-418
Abstract
Amyotrophic lateral sclerosis (ALS) is a chronic progressive neuromuscular disorder of unknown etiology, characterized by weakness, muscle wasting, fasciculations, and increased reflexes, with conserved intellect and higher functions. The neuropathology of ALS is mostly confined to damage of the motor neurons in the cerebral cortex, some motor nuclei of the brainstem, and anterior horns of the spinal cord. However, there is evidence for the involvement of other neuronal systems in the disease. In particular, damage of the dopamine neurons has been shown by neurochemical and imaging studies in the brain and spinal cord of ALS patients. Recent reports suggest that peripheral blood mononuclear cells (PBMC) may represent a useful in vivo model to study neurochemical alterations that occur in neurodegenerative disorders. Here we demonstrate the significant reduction of dopamine transporter immunoreactivity in PBMC of patients affected by ALS with respect to healthy subjects. These results extend our knowledge of damage of the dopamine system in ALS to peripheral cells. Thus, the original concept of ALS as an isolated degeneration of motor neurons seems to extend to a more widespread understanding of the disease with involvement of other neuronal systems in the central as well as peripheral nervous system.Keywords
This publication has 14 references indexed in Scilit:
- Increased Lymphocyte Dopamine β-Hydroxylase Immunoreactivity in Alzheimer’s Disease: Compensatory Response to Cholinergic Deficit?Dementia and Geriatric Cognitive Disorders, 2004
- Dopamine transporter immunoreactivity in peripheral blood lymphocytes in Parkinson's diseaseJournal of Neural Transmission, 2001
- El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2000
- Reduced dopamine in peripheral blood lymphocytes in Parkinsonʼs diseaseNeuroReport, 1999
- Cardiac sympathetic denervation in early stages of amyotrophic lateral sclerosis demonstrated by123I-MIBG-SPECTActa Neurologica Scandinavica, 1999
- Amyotrophic Lateral SclerosisSeminars in Neurology, 1998
- Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosisAnnals of Neurology, 1997
- Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's diseaseNeurology, 1996
- Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanningThe Lancet, 1993
- Biogenic amines and metabolites in spinal cord of patients with Parkinson's disease and amyotrophic lateral sclerosisJournal of Neural Transmission, 1991